Literature DB >> 7050383

Synthesis and biological activity of some very hydrophobic superagonist analogues of luteinizing hormone-releasing hormone.

J J Nestor, T L Ho, R A Simpson, B L Horner, G H Jones, G I McRae, B H Vickery.   

Abstract

The effect of increased hydrophobicity at position 6 of luteinizing hormone-releasing hormone (LH-RH) has been investigated by the incorporation of a series of 15 very hydrophobic, unnatural D-amino acids at this position. The unnatural amino acids studied can be considered analogues of phenylalanine with carbocyclic aromatic side chains consisting of substituted phenyl (e.g., 2,4,6-trimethylphenyl, p-biphenyl) or polycyclic aromatic (e.g., naphthalene, anthracene) units. When enzymatic resolution (subtilisin Carlsberg) of the most hydrophobic amino acids failed, the racemic amino acids were incorporated, and the diastereomeric LH-RH analogues were resolved by preparative high-performance liquid chromatography. The analogues were synthesized by the solid-phase technique. All of the synthetic compounds were very potent LH-RH superagonists, but [6-(3-(2-naphthyl)-D-alanine)]LH-RH, [6-(3-(2-naphthyl)-D-alanine), 7-(N alpha-methylleucine)]LH-RH and [6-(3-(2,4,6-trimethylphenyl)-D-alanine)]LH-RH appear to be among the most potent LH-RH agonist analogues yet reported when tested in a rat estrus cyclicity suppression assay designed to show the paradoxical antifertility effects of these compounds [ED50 approximately 7 x 10(-8) g; twice daily in saline]. These analogues are twice as potent as [D-Trp6,ProNHEt9]LH-RH in this assay system (i.e., approximately 200 times the potency of LH-RH).

Entities:  

Keywords:  Biology; Endocrine System; Gonadotropins; Hormones; Physiology; Pituitary Hormone Releasing Hormones--analysis

Mesh:

Substances:

Year:  1982        PMID: 7050383     DOI: 10.1021/jm00349a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Influence of average molecular weights of poly(DL-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro drug release from microspheres.

Authors:  J M Ruiz; J P Busnel; J P Benoît
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

2.  Parenteral peptide formulations: chemical and physical properties of native luteinizing hormone-releasing hormone (LHRH) and hydrophobic analogues in aqueous solution.

Authors:  M F Powell; L M Sanders; A Rogerson; V Si
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

Review 3.  Transdermal delivery of proteins.

Authors:  Haripriya Kalluri; Ajay K Banga
Journal:  AAPS PharmSciTech       Date:  2011-03-03       Impact factor: 3.246

4.  Disposition of detirelix, a potent luteinizing hormone-releasing hormone antagonist, in rats and monkeys.

Authors:  R L Chan; W Ho; A S Webb; J A LaFargue; C A Nerenberg
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

Review 5.  Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions.

Authors:  P Chrisp; K L Goa
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 6.  A benefit-risk assessment of medical treatment for uterine leiomyomas.

Authors:  Vincenzo De Leo; Giuseppe Morgante; Antonio La Marca; Maria Concetta Musacchio; Massimo Sorace; Chiara Cavicchioli; Felice Petraglia
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects.

Authors:  S Bajusz; M Kovacs; M Gazdag; L Bokser; T Karashima; V J Csernus; T Janaky; J Guoth; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Effect of gelation on the chemical stability and conformation of leuprolide.

Authors:  M M Tan; C A Corley; C L Stevenson
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

Review 9.  Gonadotrophin-releasing hormone agonists. A guide to use and selection.

Authors:  M Filicori
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

10.  Probing the GnRH receptor agonist binding site identifies methylated triptorelin as a new anti-proliferative agent.

Authors:  Kevin Morgan; Samuel P Leighton; Robert P Millar
Journal:  J Mol Biochem       Date:  2012-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.